Search Results

SHW The Sherwin-Williams Company - Fundamental Analysis

NEUTRAL
SHW Stock | Fundamental Analysis & Investment Insights
NYSE Basic Materials Specialty Chemicals
Current Price
$332.18
Analyst Target
$386.52
+16.4% Upside
52W High
$400.42
52W Low
$308.84

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Nov 16, 2025
Market cap
$84.0B
P/E
32.47
ROE
59.9%
Profit margin
11.0%
Debt/Equity
3.25
Dividend yield
0.95%

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
72%
Analysis Accuracy
Sherwin-Williams (SHW) trades at a premium valuation with strong historical profitability and consistent earnings growth, supported by an elite ROE of nearly 60% and solid gross margins above 48%. However, recent earnings misses and decelerating YoY revenue growth of just 3.2% contrast with a still-elevated P/E of 32.5x and forward P/E of 26x, suggesting limited margin of safety. The stock has underperformed peers like Linde (LIN), declining 13.6% over the past year while the sector averages show better relative momentum. Analysts maintain a 'buy' rating with a $386.52 target implying ~16% upside, but insider selling over the last six months and tight liquidity ratios raise caution on near-term sentiment and financial flexibility.

Key Strengths

Exceptional ROE of 59.94% significantly outpaces sector average of 17.98%, reflecting superior capital efficiency and pricing power
Gross margin of 48.88% demonstrates strong cost control and brand pricing strength in the specialty chemicals space
Consistent double-digit EPS growth with 12.9% YoY increase and 6.2% Q/Q improvement in latest quarter
Low dividend payout ratio of 30.13% supports long-term sustainability and room for future increases
Analyst target price of $386.52 implies meaningful 16.3% upside from current levels, indicating confidence in recovery

Key Risks

Premium valuation with P/E of 32.47 vs sector avg of 28.32 and forward P/E of 25.99, leaving little room for error
Deteriorating earnings surprise trend: only 2 beats in last 4 quarters with average miss of -0.89%
High debt/equity ratio of 3.25 far exceeds peer average of 0.65, increasing interest rate and refinancing risk
Weak liquidity profile with current ratio of 0.82 and quick ratio of 0.46, below industry norms and raising working capital concerns
Negative insider activity: $2.04M in officer sales over past 6 months with zero buys, signaling lack of confidence at executive level
AI Fair Value Estimate
Based on comprehensive analysis
$386.52
+16.4% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
64
Strong
Value
54
Future
66
Past
78
Health
50
Dividend
70
AI Verdict
SHW exhibits high-quality profitability and durable margins but trades at a steep valuation premium relative to both its growth trajectory and peer group, particularly given recent earnings volatility and elevated leverage. While the $386.52 analyst target suggests upside, weak price momentum (-13.6% over 1Y) and deteriorating insider sentiment constrain near-term catalysts.
Key drivers: Elite ROE and margin structure, Premium valuation vs growth rate, Elevated leverage and insider selling
Confidence
75%
Value
54/100

SHW trades at a significant valuation premium to peers like Linde (P/E 28.32) despite comparable revenue growth (3.2% vs 3.1%), making it one of the most expensive names in the sector without commensurate profitability or growth differentiation.

Positives
  • Forward P/E of 25.99 is lower than current P/E, suggesting some earnings recovery priced in
  • Price/Sales of 3.61 reflects brand premium in specialty chemicals
Watchpoints
  • Current P/E of 32.47 is well above sector average of 28.32 despite slower growth
  • Price/Book of 18.50 indicates extreme asset valuation, unsupported by ROA of only 9.19%
Future
66/100

While earnings growth remains positive and price momentum has stabilized (+0.1% over 1M), the 1Y return of -13.6% and underperformance vs LIN (-5.4%) highlight weak investor sentiment amid macro concerns in construction and DIY demand.

Positives
  • 12.9% YoY EPS growth and 6.2% Q/Q EPS expansion signal underlying earnings momentum
  • Analyst target implies confidence in forward recovery and margin stabilization
Watchpoints
  • Revenue growth of 3.2% is stagnant and below historical trends
  • Recent earnings misses and declining surprise trend suggest execution risks
Past
78/100

Over the past five years, SHW delivered a 42.4% total return with strong profitability and margin discipline, but the last 12 months have seen declining earnings accuracy and weakening price performance, breaking a prior uptrend.

Positives
  • Long history of strong earnings surprises, including multiple +20% beats in 2020–2023
  • Consistently high profitability with operating margin of 18.2% and profit margin of 11.05%
Watchpoints
  • Earnings surprise trend has deteriorated: average miss of -0.89% over last 4 quarters
  • Gross margin compression risk evident in recent quarters despite still-high level
Health
50/100

SHW’s balance sheet is significantly more leveraged than peers, with debt/equity over 5x the sector norm, and weak liquidity ratios that could pressure operations during downturns, especially in cyclical end markets.

Positives
  • Operating cash flow likely robust given high operating margin and stable business model
  • No reported cash burn; company maintains investment-grade credit profile
Watchpoints
  • Debt/Equity of 3.25 is extremely high vs sector average of 0.65, increasing financial risk
  • Current ratio of 0.82 and quick ratio of 0.46 indicate potential liquidity strain
Dividend
70/100

The dividend is sustainable given the low payout ratio and strong earnings base, but the sub-1% yield limits appeal in a rising rate environment, especially compared to higher-yielding peers in basic materials.

Positives
  • Dividend payout ratio of 30.13% is conservative and well-covered by earnings
  • Annual dividend rate of $3.16 provides income stability with room for growth
Watchpoints
  • Yield of 0.95% is below sector average and may not attract income-focused investors
  • No data on dividend growth history or consistency of increases

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$332.18
Analyst Target
$386.52
Upside/Downside
+16.4%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for SHW and closest competitors.

Updated 2025-11-14
Company 5Y 3Y 1Y 6M 1M 1W
SHW
The Sherwin-Williams Company
Primary
+42.4% +42.2% -13.6% -8.2% +0.1% -2.1%
ECL
Ecolab Inc.
Peer
+27.9% +75.0% +5.5% +0.3% -5.5% +1.0%
APD
Air Products and Chemicals, Inc.
Peer
+9.9% -5.1% -15.8% -5.8% +0.8% -0.1%
CTVA
Corteva, Inc.
Peer
+85.9% +2.0% +16.1% -3.3% +6.6% +2.9%
DD
DuPont de Nemours, Inc.
Peer
+64.7% +42.6% +16.6% +38.5% +20.9% -0.2%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
32.47
Forward P/E
25.99
PEG Ratio
N/A
P/B Ratio
18.5
P/S Ratio
3.61
EV/Revenue
4.12
EV/EBITDA
22.12
Market Cap
$84.0B

Profitability

Profit margins and return metrics

Profit Margin 11.05%
Operating Margin 18.2%
Gross Margin 48.88%
ROE 59.94%
ROA 9.19%

Growth

Revenue and earnings growth rates

Revenue Growth +3.2%
Earnings Growth +5.3%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +3.3%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
3.25
High debt
Current Ratio
0.82
Weak
Quick Ratio
0.46
Poor
Cash/Share
$0.98

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-03
$N/A
2025-10-28
$3.59
+4.4% surprise
2025-07-22
$3.38
-11.2% surprise
2025-04-29
$2.25
+4.1% surprise

Basic Materials Sector Comparison

Comparing SHW against 6 companies in the Basic Materials sector (2 bullish, 4 neutral, 0 bearish)
P/E Ratio
32.47
This Stock
vs
29.52
Sector Avg
+10.0% (Premium)
Return on Equity (ROE)
59.94%
This Stock
vs
17.96%
Sector Avg
+233.7% (Excellent)
Profit Margin
11.05%
This Stock
vs
7.43%
Sector Avg
+48.6% (Superior)
Debt to Equity
3.25
This Stock
vs
1.09
Sector Avg
+197.3% (Higher)
Revenue Growth
3.2%
This Stock
vs
7.23%
Sector Avg
-55.8% (Slower)
Current Ratio
0.82
This Stock
vs
1.38
Sector Avg
-40.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
SHW
The Sherwin-Williams Company
NEUTRAL $84.0B 32.47 59.9% 11.0% $332.18
ECL
Ecolab Inc.
NEUTRAL $74.2B 37.15 21.9% 12.5% $258.58
APD
Air Products and Chemicals, Inc.
NEUTRAL $58.54B - -1.9% -3.3% $259.34
CTVA
Corteva, Inc.
NEUTRAL $44.73B 26.72 6.7% 9.2% $66.0
DD
DuPont de Nemours, Inc.
BULLISH $17.01B 22.95 3.2% -6.0% $39.71

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2025-10-03 ANDERSON KERRII B Director Stock Award 29 $10,001
2025-10-03 GAMGORT ROBERT JAMES Director Stock Award 98 $33,752
2025-10-03 WILLIAMS THOMAS L II Director Stock Award 98 $33,752
2025-10-03 THAMAN MICHAEL H Director Stock Award 98 $33,752
2025-08-25 BINNS JUSTIN T Officer Sale 609 $224,611
2025-08-25 BINNS JUSTIN T Officer Option Exercise 609 $48,629
2025-08-06 LANG JAMES P Officer Sale 860 $301,301
2025-08-06 LANG JAMES P Officer Option Exercise 860 $160,691
2025-07-31 MISTYSYN ALLEN J Chief Financial Officer Gift 11,100 -
2025-07-07 ANDERSON KERRII B Director Stock Award 28 $10,001
2025-07-07 GAMGORT ROBERT JAMES Director Stock Award 97 $33,752
2025-07-07 WILLIAMS THOMAS L II Director Stock Award 97 $33,752
2025-07-07 THAMAN MICHAEL H Director Stock Award 97 $33,752
2025-06-06 REA TODD D President Sale 4,223 $1,516,733
2025-06-06 REA TODD D President Option Exercise 2,686 $635,628
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
21 analysts
Citigroup
2025-10-30
Maintains
Neutral Neutral
RBC Capital
2025-10-29
Maintains
Outperform Outperform
UBS
2025-10-29
Maintains
Buy Buy
JP Morgan
2025-10-29
Maintains
Overweight Overweight
Wells Fargo
2025-10-29
Maintains
Overweight Overweight
B of A Securities
2025-10-14
Maintains
Neutral Neutral
Wells Fargo
2025-10-10
Maintains
Overweight Overweight
UBS
2025-10-06
Maintains
Buy Buy
Citigroup
2025-10-06
Maintains
Neutral Neutral
Evercore ISI Group
2025-08-26
Maintains
Outperform Outperform